Reply

Zobair M Younossi^{1

2}, Puneetinder Kaur Mann², Mark Wymer²

Affiliations

¹ Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
² Beatty Liver and Obesity Program, Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA.

Comment

Zobair M Younossi et al. Hepatology. 2016 Oct.

. 2016 Oct;64(4):1391-3.

doi: 10.1002/hep.28587. Epub 2016 Apr 28.

Zobair M Younossi^{1

2}, Puneetinder Kaur Mann², Mark Wymer²

¹ Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
² Beatty Liver and Obesity Program, Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA.

No abstract available

Comment on

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Younossi ZM, et al. Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22. Hepatology. 2016. PMID: 26707365 Review.
Errors in meta-analysis on prevalence of nonalcoholic fatty liver disease.
Roerecke M, Rehm J, Neuman M. Roerecke M, et al. Hepatology. 2016 Oct;64(4):1389-90. doi: 10.1002/hep.28585. Epub 2016 Apr 28. Hepatology. 2016. PMID: 27038346 Free PMC article. No abstract available.
Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation?
Naderian M, Ebrahimi H, Sohrabpour AA. Naderian M, et al. Hepatology. 2016 Oct;64(4):1390-1. doi: 10.1002/hep.28586. Epub 2016 Apr 30. Hepatology. 2016. PMID: 27045003 No abstract available.